EIT Health Germany Core Partner Roche ranked as no.1 amongst Top-50 biopharmaceutical investors in the world.
The 2018 edition of the EU Industrial R&D Investment Scoreboard comprises the 2500 companies investing the largest sums in R&D in the world in 2017/18.
These companies, based in 46 countries, each invested over €25 million in R&D for a total of €736.4bn which is approximately 90% of the world’s business-funded R&D.
The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn in research and development – approximately 19% of the global estimate. The sector is the one of the most research-intensive in the world.
source: Heat Informatics © 2019